Inflammatory markers as mortality predictors in continuous ambulatory peritoneal dialysis patients

References

• Simic-Ogrizovic S, Dopsaj V, Bogavac-Stanojevic N, Obradovic I, Stosovic M, Radovic M. Serum amyloid-A rather than C-reactive protein is better predictor of mortality in hemodialysis patients. Tohoku J Exp Med. 2009;219:121–127
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(Suppl 12):S16–S23
   PubMedGoogle Scholar
• Nube MJ. The acute phase response in chronic hemodialysis patients: A marker of cardiovascular diseases? Nephrol Dial Transplant. 2002;17(Suppl 3):19–23
   PubMedGoogle Scholar
• Goldsmith D, MacGinley R, Smith A, Covic A. How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure? Nephrol Dial Transplant. 2002;17:965–969
   PubMedGoogle Scholar
• Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1994;290:697–701
   Google Scholar
• USRDS. Excerpt from the United States Renal Data System 1999 Annual Data Report. Patient mortality and survival in ESRD. Am J Kidney Dis. 1999;34(Suppl 1):S74–S86
   PubMedGoogle Scholar
• Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58:353–362
   PubMed Web of Science ®Google Scholar
• Zoccali C, Enia G, Tripepi G, Panuccio V, Mallamaci F. Clinical epidemiology of major nontraditional risk factors in peritoneal dialysis patients. Perit Dial Int. 2005;25(Suppl 3):S84–S87
   PubMedGoogle Scholar
• Stenvinkel P. Inflammation in end-stage renal disease: The hidden enemy. Nephrology. 2006;11:36–41
   PubMed Web of Science ®Google Scholar
• Bergstrom J, Heimburger O, Lindholm B, Quereshi AR. Elevated serum C-reactive protein is strong predictor of increased mortality and low serum albumin in hemodialysis (HD) (abstract). J Am Soc Nephrol. 1995;6:573
   Web of Science ®Google Scholar
• Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54:627–636
   PubMed Web of Science ®Google Scholar
• Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14:1956–1960
   PubMed Web of Science ®Google Scholar
• Zimmermann J, Herrlinger S, Pruy A, Metzger S, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658
   PubMed Web of Science ®Google Scholar
• Menon V, Greene T, Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68:766–772
   PubMed Web of Science ®Google Scholar
• Libetta C, De Nicola L, Rampino T, De Simone W, Memoli B. Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation. Kidney Int. 1996;49:506–511
   PubMedGoogle Scholar
• Wang AY-M. The “heart of peritoneal dialysis”: Residual renal function. Perit Dial Int. 2007;27:116–124
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Stenvinkel P, Yoe-Moon Wang A, Heimburger O, Lindholm B. Chronic inflammation in peritoneal dialysis: The search for the holy grail? Perit Dial Int. 2004;24:327–339
   PubMedGoogle Scholar
• Wang AY, Woo J, Lam CW, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003;14:1871–1879
   PubMed Web of Science ®Google Scholar
• Du Bois D, Du Bois EF. Clinical calorimetry X. A formula to estimate the approximate surface if height and weight be known. Arch Intern Med. 1916;17:863–871
   Google Scholar
• Keshaviah P. Adequacy of peritoneal dialysis. In: Gokal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht, The Netherlands: Kulwer Academic; 1994:419–442
   Google Scholar
• Jovanović DB. Clinical importance of determination of serum amyloid A. Srp Arh Celok Lek. 2004;132:267–271
   PubMedGoogle Scholar
• Maury CP. Comparative study of serum amyloid A protein and C-reactive protein disease. Clin Sci (London). 1985;68:233–238
   PubMed Web of Science ®Google Scholar
• Christensen MB, Langhorn R, Goddard A, et al. Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs. Can Vet J. 2014;55:161–168
   PubMedGoogle Scholar
• Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictor of sudden cardiac death. Circulation. 2002;105:2595–2599
   PubMed Web of Science ®Google Scholar
• Arima H., Kubo M, Yonemoto K, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: The Hisayama study. Arterioscler Thromb Vasc Biol. 2008;28:1385–1391
   PubMed Web of Science ®Google Scholar
• Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993;44:115–119
   PubMedGoogle Scholar
• Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: Sources, consequences, and therapy. Semin Dial. 2002;5:329–337
   Google Scholar
• Yuen JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis. 1997;30:923–927
   PubMedGoogle Scholar
• Tsirpanlis G, Bagos P, Ioannou D, et al. Exploring inflammation in hemodialysis patients: Persistent and superimposed inflammation. A longitudinal study. Kidney Blood Press Res. 2004;27:63–70
   PubMed Web of Science ®Google Scholar
• Hung CY, Chen YA, Chou CC, Yang CS. Nutritional and inflammatory markers in the prediction of mortality in Chinese hemodialysis patients. Nephron Clin Pract. 2005;100:20–26
   PubMedGoogle Scholar
• Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 1998;35:745–753
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Barany P, Lidhom B, Heimburger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002;17:1684–1688
   PubMed Web of Science ®Google Scholar
• Panichi V, Maggiore U, Taccola D, et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in hemodialysis patients. Nephrol Dial Transplant. 2004;19:1154–1160
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G. Inflammatory proteins as predictors of cardiovascular disease in patients end-stage disease. Nephrol Dial Transplant. 2004;19:(Suppl 5):v67–v72
   PubMedGoogle Scholar
• Vejakama P, Thakkinstian A, Ingsathit A, Dhanakijcharoen P, Attia J. Prognostic factors of all-cause mortalities in continuous ambulatory peritoneal dialysis: a cohort study. BMC Nephrol. 2013;14:28–37
   PubMedGoogle Scholar
• Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT. Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group. The Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline for bone metabolism and disease in CKD: Association with mortality in dialysis patients. Am J Kidney Dis. 2005;46:925–932
   PubMed Web of Science ®Google Scholar
• Wald R, Sarnak MJ, Tighiouart H, et al. Disordered mineral metabolism in hemodialysis patients: An analysis of cumulative effects in the hemodialysis (HEMO) study. Am J Kidney Dis. 2008;52:531–540
   PubMed Web of Science ®Google Scholar
• Stosovic MD, Naumovic RT, Stanojevic MLj, et al. Could the level of serum albumin be a method for assessing malnutrition in hemodialysis patients? Nutr Clin Pract. 2011;26:607–613
   PubMed Web of Science ®Google Scholar
• Simic-Ogrizovic S, Stosovic M, Novakovic I, et al. Fuzzy role of hyperhomocysteinemia in hemodialysis patients' mortality. Biomed Pharmacother. 2006;60:200–207
   PubMedGoogle Scholar
• Unsal A, Koc Y, Basturk T, et al. Clinical outcomes and mortality in peritoneal dialysis patients: A 10-year retrospective analysis in a single center. Clin Nephrol. 2013;80:270–279
   PubMedGoogle Scholar
• Yang X, Yi C, Liu X, et al. Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: A 5-year clinical cohort study. Diabetes Res Clin Pract. 2013;100:354–361
   PubMed Web of Science ®Google Scholar
• Calò LA, Savica V, Piccoli A, Fusaro M, D'Angelo A, Davis PA. Reduction of hyperphosphatemia is related with the reduction of C-reactive protein in dialysis patients. Study in sevelamer-resistant dialysis patients treated with chitosan chewing gum as salivary phosphate binder. Ren Fail. 2011;33:11–14
   PubMed Web of Science ®Google Scholar